Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form

21Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A specific, stability-indicating reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed and validated for the estimation of perindopril erbumine (PDE) in tablet dosage form. The HPLC method showed adequate separation of PDE from its degradation products. The separation was achieved on a Phenomenex Luna C18 column (250 × 4.6 mm × 5 μm) using a mobile phase composition of 0.2% trifluoroacetic acid buffer and acetonitrile in the ratio of 60:40 (pH adjusted to 3 with ammonia) at a flow rate of 1 mL/min. The injection volume was 20 μL and the wavelength of detection was kept at 215 nm. Stress studies were performed with 1 mg/mL of each drug, starting with mild conditions and followed by stronger conditions to achieve sufficient degradation at approximately 5-20%. The linearity of the proposed method was investigated in the range of 2.5 to 50 μg/mL for PDE. The limits of detection and quantification were found to be 0.75 and 2.3 μg/mL, respectively. © 2013 The Author. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Dugga, H. H. T., Peraman, R., & Nayakanti, D. (2014). Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form. Journal of Chromatographic Science, 52(4), 315–320. https://doi.org/10.1093/chromsci/bmt031

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free